16.6: Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.

Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic pumps to regulate drug diffusion or dissolution over time.

Stimuli-activated systems respond to physical, chemical, or biological triggers such as temperature, pH, or enzymes. Thermo-responsive polymers alter their structure to control drug diffusion, pH-sensitive carriers release drugs in specific environments, and enzyme-responsive systems break down in the presence of biological catalysts to ensure drug release at the desired location. This approach enables drug delivery to adapt to physiological conditions, improving therapeutic outcomes.

Site-targeted systems deliver drugs directly to specific tissues or organs, reducing distribution to non-target sites and minimizing systemic toxicity. Targeting can be passive, such as exploiting the enhanced permeability and retention effect in tumors, or active, using ligands, antibodies, or nanoparticles to bind to specific cell receptors.

Rate-programmed and stimuli-activated systems consist of three key components: the drug, a rate-controlling element like polymers or coatings that regulate diffusion, and an energy source, which can be external stimuli such as ultrasound or biological triggers like pH changes. These approaches optimize drug therapy by maintaining stable plasma drug levels, reducing dosing frequency, improving patient compliance, lowering drug doses, and minimizing side effects. Applications include oncology, cardiovascular diseases, neurological disorders, and infectious diseases, where precision drug delivery is crucial for therapeutic success.

Modified-release delivery systems enhance therapeutic efficacy and minimize side effects by controlling drug release.

Depending on their technical sophistication, these delivery systems are classified as rate-programmed, stimuli-activated, and site-targeted systems.

Rate-programmed systems release the drug at specific, pre-determined rates, ensuring consistent therapeutic levels.

Stimuli-activated systems respond to physical, chemical, or biological stimuli—such as temperature, pH, or enzymes— to trigger drug release.

Site-targeted systems deliver the drug to the intended site, limiting distribution to non-target tissues and reducing side effects.

Both rate-programmed and stimuli-activated systems comprise three essential components: the drug, a rate-controlling element, and a mechanism to initiate or sustain release.

Site-targeted systems enhance therapeutic outcomes by improving drug localization and reducing toxicity.

Collectively, these approaches optimize therapy by lowering required doses to maintain steady-state plasma levels.